Literature DB >> 10435168

Risk factors for acquisition of gentamicin-resistant enterococcal infection: a case-controlled study.

M Viagappan1, R E Holliman.   

Abstract

High-level gentamicin-resistant enterococci present problems in the treatment of infected patients, especially as synergy between penicillin and gentamicin is lost. Previous studies have suggested various risk factors for the acquisition of these enterococci. A case-controlled study was performed on 17 patients infected with resistant enterococci and 26 infected with sensitive strains who attended a London hospital. The key risk factors for acquisition of infection with high-level gentamicin-resistant enterococci were found to be prior prolonged antibiotic treatment, use of five or more antibiotics, and the presence of a urinary catheter. It is proposed that infection control measures should be targeted at patients at higher risk. In addition, control of antibiotic usage in a hospital may help to prevent acquisition and spread of these organisms.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10435168      PMCID: PMC1741254          DOI: 10.1136/pgmj.75.884.342

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  9 in total

1.  High level gentamicin resistance in enterococcal and streptococcal isolates from blood culture.

Authors:  P J Stevens; N A Hutchinson; R E Holliman
Journal:  Med Lab Sci       Date:  1992-03

2.  The Garrod Lecture. The enterococcus: a classic example of the impact of antimicrobial resistance on therapeutic options.

Authors:  R C Moellering
Journal:  J Antimicrob Chemother       Date:  1991-07       Impact factor: 5.790

3.  Evidence for clonal spread of a single strain of beta-lactamase-producing Enterococcus (Streptococcus) faecalis to six hospitals in five states.

Authors:  B E Murray; K V Singh; S M Markowitz; H A Lopardo; J E Patterson; M J Zervos; E Rubeglio; G M Eliopoulos; L B Rice; F W Goldstein
Journal:  J Infect Dis       Date:  1991-04       Impact factor: 5.226

4.  Nosocomial infection by gentamicin-resistant Streptococcus faecalis. An epidemiologic study.

Authors:  M J Zervos; C A Kauffman; P M Therasse; A G Bergman; T S Mikesell; D R Schaberg
Journal:  Ann Intern Med       Date:  1987-05       Impact factor: 25.391

5.  High-level resistance to gentamicin in Streptococcus faecalis: risk factors and evidence for exogenous acquisition of infection.

Authors:  M J Zervos; S Dembinski; T Mikesell; D R Schaberg
Journal:  J Infect Dis       Date:  1986-06       Impact factor: 5.226

6.  Risk factors for acquisition of gentamicin-resistant enterococci. A multivariate analysis.

Authors:  P Axelrod; G H Talbot
Journal:  Arch Intern Med       Date:  1989-06

7.  Gentamicin-resistant enterococci and endocarditis.

Authors:  R Holliman; E Smyth
Journal:  Postgrad Med J       Date:  1989-06       Impact factor: 2.401

8.  High-level gentamicin resistance in Enterococcus faecalis bacteremia.

Authors:  G A Noskin; M Till; B K Patterson; J T Clarke; J R Warren
Journal:  J Infect Dis       Date:  1991-12       Impact factor: 5.226

9.  Aortic endocarditis caused by gentamicin-resistant Enterococcus faecalis.

Authors:  M L Fernández-Guerrero; C Barros; J L Rodriguez Tudela; R Fernández Roblas; F Soriano
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-08       Impact factor: 3.267

  9 in total
  2 in total

Review 1.  Epidemiological interpretation of studies examining the effect of antibiotic usage on resistance.

Authors:  Vered Schechner; Elizabeth Temkin; Stephan Harbarth; Yehuda Carmeli; Mitchell J Schwaber
Journal:  Clin Microbiol Rev       Date:  2013-04       Impact factor: 26.132

2.  Risk factors for development of aminoglycoside resistance among gram-negative rods.

Authors:  Stefan E Richter; Loren Miller; Jack Needleman; Daniel Z Uslan; Douglas Bell; Karol Watson; Romney Humphries; James A McKinnell
Journal:  Am J Health Syst Pharm       Date:  2019-10-30       Impact factor: 2.637

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.